Table 2.
Changes in plasma markers of insulin-resistant adult women, participants of 12-weeks of high-intensity interval, resistance, concurrent training, or a control group.
| Outcomes | Time | CGa | HIITb | RTc | CTd |
|---|---|---|---|---|---|
| (n=) | 13 | 14 | 8 | 10 | |
| Fasting plasma glucose (mg/dl) | Pre | 102.0±9.0 | 101.0±0.9 | 98.0±13.0 | 99.0±5.0 |
| Post24h | 103.1±9.4 | 95.3±12.1** | 92.9±9.6 | 96.7±4.4 | |
| Post72h | 103.4±8.8 | 96.5±12.8 | 93.9±5.6 | 103.3±6.1*** | |
| Fasting insulin (μUI/dl) | Pre | 3.6±1.7 | 4.6±2.9 | 4.9±4.6 | 4.5±4.8 |
| Post24h | 3.7±1.7 | 4.9±5.0 | 4.3±4.1 | 4.7±4.3 | |
| Post72h | 3.8±1.7 | 4.4±2.8 | 2.8±2.0 | 4.5±4.2 | |
| HOMA-IR | Pre | 0.9±0.5 | 1.2±0.8 | 1.3±1.5 | 1.1±1.1 |
| Post24h | 1.0±0.5 | 1.2±1.2 | 1.1±1.2 | 1.1±1.1 | |
| Post72h | 1.0±0.5 | 1.1±0.7 | 0.6±0.2 | 1.2±1.2 |
Significant differences from pre- to post-24h by two-way ANOVA (group×times) at p<0.001.
Significant differences from post-24h to post-72h by two-way ANOVA (Group×Time) at p<0.001.
Data are shown as mean and±SD. Groups are described as: Control group (CG), High-intensity interval (HIIT), Resistance training (RT), and Concurrent training (CT). Bold values denote significant pre-post changes at p<0.05 by repeated evaluations×group. Univariant analysis was applied to test baseline differences among groups denoted (a, b, c, or d). value of p significant differences was remarked in bold.